Perm varsity shooting: All Indian students safe, says embassy
Darpan News Desk IANS, 20 Sep, 2021 11:11 AM
Moscow, Sep 20 (IANS) All Indian students at Russia's Perm State University, where at least eight people were killed and 24 others injured on Monday as a gunman went on a rampage, are safe, the Indian Embassy said.
"Shocked at horrific attack at Perm State University in Russia; our deep condolences for loss of life and best wishes for early recovery of those injured. Embassy is in touch with local authorities and the representatives of Indian students. All Indian students at Perm State Medical University are safe," the Embassy said.
A recent batch of students for the Perm State Medical University (2020-21) departed from New Delhi on August 29.
The university, one of the oldest in Russia, is located in Perm, around 1,300 km east of Moscow.
The go-ahead for the vaccine developed by American drugmaker Pfizer and Germany's BioNTech comes as the virus surges again in the United States and Europe, putting pressure on hospitals and morgues in some places and forcing new rounds of restrictions that have devastated economies.
Announcing the results on Monday, Moderna said it has submitted emergency use authorisation from the US Food and Drug Administration (FDA), to apply for a conditional marketing authorisation with the European Medicines Agency (EMA) and to progress with the rolling reviews, which have already been initiated with international regulatory agencies.
Protest by thousands of farmers from Punjab and Haryana took place in New Delhi over the weekend entering its fifth day Monday as the farmers continue to showcase their displeasure against the Centre's new farm laws.
Monday's delivery of an 18-and-a-half foot tall Fraser fir by horse-drawn carriage signalled the kickoff of the usual array of White House holiday events that will include the annual turkey pardon and Christmas and Hanukkah events.
The results are based on an interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca.
The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
.jpg "U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population")
